Global IV Cannula Market to Reach US$74.7 Million by 2033, with North America Leading at a 32.5% Global Market Share

The Global IV Cannula Market reached US$45.9 million in 2024 and is expected to reach US$74.7 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/iv-cannula-market?pratik

The IV cannula market is growing steadily due to various factors such as the increasing prevalence of chronic diseases, rising surgical procedures, advancements in healthcare infrastructure, and expanding home healthcare services. The shift towards home healthcare and outpatient care has increased the demand for IV cannulas, as many patients now receive treatments like antibiotics, chemotherapy, or hydration therapy at home.

United States industry development
✅ November 2025: Global Info Research released a report on the Peripheral IV Cannula market, highlighting advances in manufacturing and increasing demand driven by rising chronic disease prevalence and intravenous therapy needs.

✅ October 2025: Several US manufacturers introduced safety-engineered IV cannulas featuring smaller gauge needles and integrated sensors for real-time monitoring, aiming to reduce complications and enhance patient comfort.

✅ August 2025: The US FDA conducted facility inspections with an emphasis on compliance and quality control improvements in IV cannula manufacturing to ensure safer medical device standards.

Europe Industry development
✅ November 2025: European companies focused on developing biocompatible, disposable IV cannulas to address patient safety and convenience, responding to increasing healthcare regulatory requirements.

✅ September 2025: Leading European medical device firms launched advanced IV cannula models with improvements in needle design and post-market surveillance data integration to minimize infections and thrombosis risk.

✅ July 2025: The European healthcare sector witnessed growth in demand for minimally invasive IV cannulas catering to an aging population, driving innovation in product design and materials for enhanced patient comfort and safety.

Recent Merges & acquisition
→ In July 2025, Teleflex Incorporated completed the acquisition of BIOTRONIK's Vascular Intervention business for about €760 million a deal that broadens Teleflex's vascular-access and interventional device portfolio, which overlaps with IV/vascular-access markets.

→ In July 2025, Terumo Corporation acquired a majority stake in Medplast, a medical-device firm specializing in IV therapy accessories. That move bolsters Terumo's capacity in IV devices, including cannulas and related products.

→ In September 2025, Avanos Medical acquired Nexus Medical, a leader in needleless connector technology expanding Avanos' specialty nutrition and IV-therapy systems business, which is adjacent to the IV cannula / vascular access segment.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=iv-cannula-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Market Segmentation-

Segmentation by Product Type
→ Peripheral IV Cannulas: The largest product segment, accounting for over 60% of the global market share due to their widespread use in routine hospital procedures, emergency care, and outpatient settings. They are favored for ease of insertion and cost-effectiveness.

→ Central IV Cannulas: Serve critical care, oncology, and long-term therapies, having a smaller share but essential for situations requiring reliable central venous access.
→ Winged IV Cannulas: Also known as butterfly needles, used for specialized applications where precision and patient comfort are critical.

→ Others: Include less common types tailored to specific clinical needs.

Segmentation by Material
→ Plastic: Dominates the market with about 70% revenue share, mainly due to disposability and safety features reducing infection risks.

→ Metal: Stainless steel cannulas are used for durability and specific procedural needs.

→ Silicone and Others: Increasingly used for patient comfort and specialized uses, but hold smaller market shares compared to plastic.

Segmentation by Application
→ Hospitals: The dominant application segment with over 55% market share, driven by a high volume of inpatient admissions, surgeries, and emergency care needing reliable IV access.

→ Clinics: Growing segment, driven by outpatient care trends and minimally invasive procedures.

→ Ambulatory Surgical Centers, Homecare, and Others: Smaller but expanding segments, especially homecare, which is growing due to more infusion therapies administered outside hospital settings.

Regional insights:-
→ North America holds the largest market share in the IV Cannula market, driven by high healthcare spending, advanced medical technologies, and a significant number of surgical procedures. The U.S. alone is projected to hold around 32.5% of the global market in 2025.

→ Europe follows North America with a substantial market share due to advanced healthcare infrastructure and a large elderly population.

→ Asia-Pacific is the fastest-growing region in the IV Cannula market. This growth is fueled by rising healthcare expenditures, increasing prevalence of chronic diseases, expanding healthcare infrastructure, and growing medical tourism.

→ Other regions include the Middle East & Africa and Latin America, which are growing but hold smaller shares compared to North America, Europe, and Asia-Pacific.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/iv-cannula-market?pratik

Key Players:-
Becton, Dickinson and Company, Nipro Corporation, Romsons Scientific & Surgical Pvt. Ltd., Medtronic plc, Cruzine, MRK Healthcare Pvt. Ltd., Bio Med Healthcare Products Pvt Ltd, AdvaCare Pharma, iLife Medical Devices Pvt Ltd, Neotec Medical.

→ Becton, Dickinson and Company (BD) is one of the largest global medical technology companies known for innovation in medical devices, including IV cannulas. BD has a strong presence in this market with advanced product designs and a global footprint.

→ Medtronic plc is another leading player, widely recognized for its broad range of medical devices, including cannulas. Medtronic commands a significant market share globally, supported by extensive R&D and product diversification. It is especially influential in North America, where the cannula market is large and technologically advanced.

→ Nipro Corporation also stands as a top competitor with a diverse portfolio of IV cannulas and related medical devices. Nipro has a strong presence in Asia-Pacific and other key markets and competes closely with BD and Medtronic in terms of market share and product offerings.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.